Related Experiment Video
Updated: Dec 23, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Non-ventilator health care-associated pneumonia (NV-HAP): Pediatrics
1Infection Prevention, Children's Hospital of Philadelphia, Philadelphia, PA.
Insights
Data on pediatric nonventilator health care-associated pneumonia (NV-HAP) is limited. This review covers NV-HAP epidemiology, risk factors, and prevention strategies in children, focusing on reducing viral transmission.
Area of Science:
- Pediatric infectious diseases
- Hospital-acquired infections
- Public health surveillance
Background:
- Nonventilator health care-associated pneumonia (NV-HAP) is a significant concern in pediatric populations.
- Limited data exists on NV-HAP prevalence, risk factors, and prevention in children.
- Understanding NV-HAP is crucial for improving patient outcomes in healthcare settings.
Purpose of the Study:
- To review the current epidemiology of NV-HAP in children.
- To identify key risk factors associated with NV-HAP in pediatric patients.
- To discuss current surveillance challenges and effective prevention strategies for pediatric NV-HAP.
Main Methods:
- Literature review of existing studies on pediatric NV-HAP.
- Analysis of epidemiological data and risk factors.
- Evaluation of surveillance definitions and case ascertainment methods.
- Synthesis of prevention strategies, with a focus on viral transmission.
Main Results:
- Paucity of data on NV-HAP prevalence and risk factors in children.
- Challenges in establishing standardized surveillance definitions and case ascertainment.
- Viral, fungal, and bacterial infections are implicated in pediatric NV-HAP.
- Need for pediatric-specific prevention strategies, particularly for viral transmission.
Conclusions:
- Further research is needed to establish NV-HAP epidemiology in children.
- Improved surveillance methods are required for accurate case identification.
- Targeted prevention strategies, especially for viral infections, are essential for reducing pediatric NV-HAP.
Abstract:
There is a paucity of data on the prevalence, risk factors or prevention of nonventilator health care-associated pneumonia (NV-HAP) in children. As with adults, viral, fungal and bacterial infections can lead to NV-HAP, but surveillance definitions and case ascertainment remain a challenge. This section will review the known epidemiology of NV-HAP in the pediatric population, risk factors, surveillance, and prevention practices. Prevention strategies specific to pediatrics, aimed at reducing risk of viral transmission to hospitalized children will be discussed.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

